Nolvaxyl identifies tamoxifen citrate, a medicine that interacts with estrogen receptors throughout the body. Its anti-estrogenic activity in breast tissue makes it an important endocrine therapy for selected estrogen-receptor-positive breast cancers.
Tamoxifen may be used in both treatment and risk-reduction settings, depending on the patient’s circumstances and clinical assessment. Its tissue-selective activity means that its effects are not identical across all organs.
This product specifies 20mg tablets. Treatment can be associated with hot flashes and other menopausal symptoms, while less common but important concerns include blood clots and endometrial abnormalities.
Reviews
There are no reviews yet.